Schering-Plough and Teva before joining DIANT in 2022. He joined as one of the early employees at DIANT and has helped build the company’s sales pipeline and sales strategy. Jim is very passionate about the company’s mission to help deliver the next generation of nanoparticle processing technology to the pharma market and is looking forward to expanding DIANT’s global reach.